Who owns ADARx Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ADRX from SEC Form 13F filings across 62 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 62 institutions disclosed 76.8M shares of ADARx Pharmaceuticals, Inc. worth $1.53B — about 476% of shares outstanding; the largest disclosed holder is ORBIMED ADVISORS LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
62
13F holders
$1.53B
value, 2026 filers
476%
of shares outstanding (76.8M sh)
62
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ADRX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLCNEW | 24.2M | $482.7M | 8.8% | 150.1% | new |
| 2 | SR ONE CAPITAL MANAGEMENT, LPNEW | 9.9M | $198.1M | 17.2% | 61.6% | new |
| 3 | Bain Capital Life Sciences Investors, LLCNEW | 6.7M | $134.2M | 9.0% | 41.7% | new |
| 4 | TCG Crossover Management, LLCNEW | 4.1M | $82.1M | 2.3% | 25.5% | new |
| 5 | FMR LLCNEW | 3.6M | $72.7M | 0.0% | 22.6% | new |
| 6 | PRICE T ROWE ASSOCIATES INC /MD/NEW | 2.9M | $57.7M | 0.0% | 17.9% | new |
| 7 | BlackRock, Inc.NEW | 2.3M | $46.6M | 0.0% | 14.5% | new |
| 8 | Capital International InvestorsNEW | 2.1M | $42.5M | 0.0% | 13.2% | new |
| 9 | Siren, L.L.C.NEW | 1.9M | $38.4M | 0.9% | 11.9% | new |
| 10 | ALLIANCEBERNSTEIN L.P.NEW | 1.7M | $34.3M | 0.0% | 10.7% | new |
| 11 | Venrock Adviser, LLCNEW | 1.6M | $32.4M | 1.6% | 10.1% | new |
| 12 | T. Rowe Price Investment Management, Inc.NEW | 1.6M | $32.0M | 0.0% | 10% | new |
| 13 | Woodline Partners LPNEW | 1.5M | $29.2M | 0.1% | 9.1% | new |
| 14 | MARSHALL WACE, LLPNEW | 1.3M | $26.6M | 0.0% | 8.3% | new |
| 15 | Commodore Capital LPNEW | 1.3M | $25.1M | 1.9% | 7.8% | new |
| 16 | Capital World InvestorsNEW | 1.2M | $23.9M | 0.0% | 7.4% | new |
| 17 | EcoR1 Capital, LLCNEW | 1.1M | $22.9M | 1.0% | 7.1% | new |
| 18 | Cormorant Asset Management, LPNEW | 962,898 | $19.2M | 1.3% | 6% | new |
| 19 | FRANKLIN TEMPLETON INCNEW | 900,000 | $13.5M | 0.0% | 5.6% | new |
| 20 | Redmile Group, LLCNEW | 769,345 | $15.3M | 1.1% | 4.8% | new |
| 21 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/NEW | 650,360 | $13.0M | 0.0% | 4% | new |
| 22 | GordonMD Global Investments LPNEW | 450,000 | $9.0M | 5.4% | 2.8% | new |
| 23 | MILLENNIUM MANAGEMENT LLCNEW | 432,280 | $8.6M | 0.0% | 2.7% | new |
| 24 | Blackstone Inc.NEW | 421,701 | $8.4M | 0.0% | 2.6% | new |
| 25 | CITADEL ADVISORS LLCNEW | 340,987 | $6.8M | 0.0% | 2.1% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.